CTOs on the Move

Allogene

www.allogene.com

 
Allogene Therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor T-cell (CAR T) therapy directed at blood cancers and solid tumors. Founded and led by former Kite Pharma executives who bring unrivaled clinical development acumen in cell therapy, Allogene is well-positioned to further the potential of allogeneic cell therapy for patients. Allogeneic CAR T therapies are engineered from cells of healthy donors and stored for “off-the-shelf” use in patients. This approach eliminates the need to create personalized therapy from a patient`s own cells, simplifies manufacturing, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.allogene.com
  • 270 Littlefield Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.457.2700

Executives

Name Title Contact Details
Nancy Saputra
 IT Director, Systems, Cloud, and Information Security Profile
Timothy Moore
 Chief Technical Officer Profile
Timothy Moore
 Chief Technology Officer Profile
Alison Moore
 Chief Technical Officer Profile
Alison Moore
 Executive Vice President of Operations and Chief Technical Officer Profile

Funding

Allogene raised $300M on 04/03/2018
Allogene raised $411.8M on 04/19/2018
Allogene raised $120M on 09/07/2018

Similar Companies

Discovery Genomics

Discovery Genomics, Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Interleuken Genetics

Interleuken Genetics is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nutcracker Therapeutics

Nutcracker Therapeutics is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA therapeutics platform. Armed with this high-tech advantage, we have developed a wholly owned pipeline of RNA therapeutic programs and established partnership initiatives with top clinical investigators at several leading institutions across the globe. With our platform`s ability to accelerate the development of life-changing RNA therapeutics, we seek to advance breakthrough RNA therapies at high velocity through all stages of development across a variety of indications. Our technology platform has the potential to significantly reduce costs and cycle times for RNA therapeutic development, with dramatic advantages in capacity scaling and point-of-care delivery over other RNA manufacturing approaches.

iCyt Mission Technology

iCyt Mission Technology is a Champaign, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ChipCare

ChipCare is a Toronto based start-up company developing a point of care blood testing platform for the global health market. The Company`s diagnostic platform is extremely mobile, simple to use, inexpensive and produces laboratory quality results. From single drops of blood, health workers in remote locations can rapidly and accurately perform tests to diagnose or monitor a range of infectious and non-communicable diseases.